Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases.

Autor: HIROKI IZUMI1 h.izumi@med.tottori-u.ac.jp, TADASHI IGISHI1, AKIRA YAMASAKI1, KENNICHI TAKEDA1, MASAAKI YANAI1, NATSUMI TANAKA1, TOMOHIRO SAKAMOTO1, SHIZUKA NISHII-ITO1, HIROKAZU TOUGE1, MASAHIRO KODANI1, SHINGO MATSUMOTO1, YUJI KAWASAKI2, EIJI SHIMIZU1
Zdroj: Molecular & Clinical Oncology. 2017, Vol. 7 Issue 6, p1000-1004. 5p.
Databáze: Academic Search Ultimate